FDA NDA · NDA220341
BRYTLY
Sponsor: ALCON LABORATORIES, INC.
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA220341
TYPE
NDA
ORIGINAL APPROVAL
2026-10-16
LATEST ACTION
2026-10-16
DOSAGE FORM
SOLUTION/ DROPS
MARKETING STATUS
Over-the-counter
Products
BRYTLYOver-the-counter
BRYTLY (APRACLONIDINE) 0.125% · SOLUTION/ DROPS
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →